HHS Announces the Availability of $25.5 Billion in COVID-19 Provider Funding
The U.S. Department of Health and Human Services (HHS) is making $25.5 billion in new funding available for healthcare providers affected by the COVID- 19 pandemic.
OCR Issues Guidance on HIPAA, COVID-19 Vaccinations and the Workplace
The U.S. Department of Health and Human Services’ Office for Civil Rights (OCR) issued guidance to help the public understand when the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule applies to disclosures and requests for information about whether a person has received a COVID-19 vaccine.
Universal Flu Vaccines Advance from Concept to Clinical Trials
“Scientists have identified components of the influenza virus that do not really change muchat all. The critical challenge is getting a vaccine to induce a response to those components.”
— Anthony Fauci, MD, Director, National Institute of Allergy and Infectious Diseases
Anti-COVID Monoclonal Cocktails
Newly created treatments for high-risk COVID-19 patients have proved highly effective. Unfortunately, challenges with their distribution and administration have limited their use.
Multisystem Inflammatory Syndrome in Children: A Complication of COVID-19
Much remains to be learned about this new condition affecting a growing number of children. However, it is hoped with increased vaccination and fewer cases of the SARS-CoV-2 virus, case numbers of MIS-C will also go down.
Against the Storm: High-Dose IVIG as an Immunoregulatory Treatment Strategy for Severe COVID-19
While there may be no “magic bullet” to treat cytokine storm, one widely used immunomodulatory agent in particular — polyclonal intravenous immune globulin (IVIG) purified from healthy donor plasma — is distinguished by the simple fact that it is anything but a narrowly targeted treatment.
COVID-19 Vaccines: Where Are We Now?
With three vaccines in circulation and three more on the horizon, is the end of the COVID-19 pandemic in sight?
Long-Term Effects of COVID-19
Long-haul COVID, now termed PASC, is a very real effect of the SARs-CoV-2 virus, but few physicians are familiar with the symptoms and where to send patients for treatment.
Enduring a Persistent Pandemic and Preparing for the Next
It’s almost a year since the pandemic first began ravaging the U.S., leaving healthcare providers grappling with how to care for the millions of Americans who have contracted the coronavirus. Still, scientists do not fully understand how to prevent or treat It.
Pandemic Preparedness: Ensuring the U.S. Is Ready for the Next One?
After several federal agencies spent two decades and tens of billions of dollars preparing for the next pandemic, critics were not shy about pointing out how unprepared the United States was for the current SARS-Cov-2 pandemic.
